Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 2178469, 10 pages
https://doi.org/10.1155/2018/2178469
Review Article

Age Is Not a Limiting Factor in Interventional Radiotherapy (Brachytherapy) for Patients with Localized Cancer

1Radiation Oncology Section, Department of Surgery and Biomedical Sciences, University of Perugia and Perugia General Hospital, Perugia, Italy
2Interdisciplinary Brachytherapy Unit, University of Lübeck/UKSH-CL, Lübeck, Germany
3Polo Scienze Oncologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy
4Radiation Oncology Section, Perugia General Hospital, Perugia, Italy
5Polo Scienze Oncologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Gruppo Italiano di Oncologia Geriatrica (GIOGER), Roma, Italy
6Polo Scienze Oncologiche ed Ematologiche, Istituto di Radiologia, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy

Correspondence should be addressed to Valentina Lancellotta; ti.gpinu@attollecnal.anitnelav

Received 18 August 2017; Revised 4 December 2017; Accepted 25 December 2017; Published 21 January 2018

Academic Editor: Pierfrancesco Franco

Copyright © 2018 Valentina Lancellotta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. W. Kennedy, J. S. Flagg, and K. D. Webster, “Gynecologic cancer in the very elderly,” Gynecologic Oncology, vol. 32, no. 1, pp. 49–54, 1989. View at Publisher · View at Google Scholar · View at Scopus
  2. J. K. Schwarz, S. Beriwal, J. Esthappan et al., “Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer,” Brachytherapy, vol. 14, no. 5, pp. 587–599, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Colloca, A. Corsonello, E. Marzetti et al., “Treating cancer in older and oldest old patients,” Current Pharmaceutical Design, vol. 21, no. 13, pp. 1699–1705, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Wildiers, P. Heeren, M. Puts et al., “International society of geriatric oncology consensus on geriatric assessment in older patients with cancer,” Journal of Clinical Oncology, vol. 32, no. 24, pp. 2595–2603, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Balducci, G. Colloca, M. Cesari, and G. Gambassi, “Assessment and treatment of elderly patients with cancer,” Surgical Oncology, vol. 19, no. 3, pp. 117–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. P. Fried and W. J. Hall, “Editorial: Leading on behalf of an aging society,” Journal of the American Geriatrics Society, vol. 56, no. 10, pp. 1791–1795, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. F. F. Holmes and H. Erwin, “Cancer Stage‐to‐Age Relationship: Implications for Cancer Screening in the Elderly,” Journal of the American Geriatrics Society, vol. 29, no. 2, pp. 55–57, 1981. View at Publisher · View at Google Scholar · View at Scopus
  8. N. A. Rodrigues, D. Dillon, D. Carter, N. Parisot, and B. G. Haffty, “Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women,” Cancer, vol. 97, no. 6, pp. 1393–1403, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. S. M. Teeter, F. F. Holmes, and M. J. McFarlane, “Lung carcinoma in the elderly population. Influence of histology on the inverse relationship of stage to age,” Cancer, vol. 60, no. 6, pp. 1331–1336, 1987. View at Publisher · View at Google Scholar · View at Scopus
  10. C. H. Geisler, “Autologous transplantation and management of younger patients with mantle cell lymphoma,” Best Practice & Research Clinical Haematology, vol. 25, no. 2, pp. 211–220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Wasil, S. M. Lichtman, V. Gupta, and S. Rush, “Radiation therapy in cancer patients 80 years of age and older,” American Journal of Clinical Oncology, vol. 23, no. 5, pp. 526–530, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Geinitz, F. B. Zimmermann, and M. Molls, “Radiotherapy of the elderly patient. Radiotherapy tolerance and results in older patients,” Strahlenther Onkol, vol. 175, pp. 175–119, 1999. View at Google Scholar
  13. B. Zachariah, L. Balducci, G. V. Venkattaramanabalaji, L. Casey, H. M. Greenberg, and J. A. DelRegato, “Radiotherapy for cancer patients aged 80 and older: A study of effectiveness and side effects,” International Journal of Radiation Oncology Biology Physics, vol. 39, no. 5, pp. 1125–1129, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Chen and W. Nadalin, “Pecularities of radiation therapy in the elderly,” Radiologia Brasileira, vol. 43, pp. 324–329, 2010. View at Google Scholar
  15. H. Geinitz, F. B. Zimmermann, and M. Molls, “Radiotherapy of the elderly patient. Radiotherapy tolerance and results in older patients,” Strahlenther Onkol, vol. 175, pp. 119–127, 1999. View at Google Scholar
  16. B. S. Gill, B. V. Chapman, K. J. Hansen, P. Sukumvanich, and S. Beriwal, “Primary radiotherapy for nonsurgically managed Stage I endometrial cancer: Utilization and impact of brachytherapy,” Brachytherapy, vol. 14, no. 3, pp. 373–379, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. I. H. Kunkler, R. Audisio, Y. Belkacemi et al., “Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: The international society of geriatric oncology (SIOG) task force,” Annals of Oncology, vol. 25, no. 11, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. T.-V. Nguyen and D. G. Petereit, “High-dose-rate brachytherapy for medically inoperable stage I endometrial cancer,” Gynecologic Oncology, vol. 71, no. 2, pp. 196–203, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Yancik, “Population aging and cancer: a cross-national concern,” Cancer Journal, vol. 11, no. 6, pp. 437–441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. G. E. Hanks, T. E. Schultheiss, A. Hanlon, and J. B. Owen, “Patterns of radiation treatment of elderly patients with prostate cancer,” Cancer, vol. 74, no. 7 S, pp. 2174–2177, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Scalliet, D. Van den Weingaert, and E. Van der Schuren, “Cancer in the Elderly. Treatment and Research,” Oxford:oxford medical publications, pp. 28–37, 1994. View at Google Scholar
  22. L. Bergman, G. Dekker, F. E. van Leeuwen, S. J. Huisman, F. S. A. M. van dam, and J. A. van Dongen, “The effect of age on treatment choice and survival in elderly breast cancer patients,” Cancer, vol. 67, no. 9, pp. 2227–2234, 1991. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Montemaggi, A. G. Morganti, R. R. Dobelbower Jr. et al., “Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: Is it just for palliation?” Radiology, vol. 199, no. 3, pp. 861–866, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. J. R. Diaz‐Pavon, F. Cabanillas, A. Majlis, and F. B. Hagemeister, “Outcome of Hodgkin's disease in elderly patients,” Hematological Oncology, vol. 13, no. 1, pp. 19–27, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Lemanski, D. Azria, S. Gourgon-Bourgade et al., “Intraoperative radiotherapy in early-stage breast cancer: results of the Montpellier phase II trial,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 3, pp. 698–703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. E. Wegner, S. Beriwal, D. E. Heron et al., “Definitive radiation therapy for endometrial cancer in medically inoperable elderly patients,” Brachytherapy, vol. 9, no. 3, pp. 260–265, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. A. M. Marijnen, “External Beam Radiotherapy and High Dose Rate Brachytherapy for Medically Unfit and Elderly Patients,” Clinical Oncology, vol. 19, no. 9, pp. 706–710, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. P. Gerard, O. Chapet, C. Ortholan, K. Benezery, N. Barbet, and P. Romestaing, “French Experience with Contact X-ray Endocavitary Radiation for Early Rectal Cancer,” Clinical Oncology, vol. 19, no. 9, pp. 661–673, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Maingon, S. Guerif, R. Darsouni et al., “Conservative management of rectal adenocarcinoma by radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 40, no. 5, pp. 1077–1085, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-P. Gerard, A.-C. Frin, J. Doyen et al., “Organ preservation in rectal adenocarcinoma (T1) T2-T3 Nx M0. Historical overview of the Lyon Sud-Nice experience using contact X-ray brachytherapy and external beam radiotherapy for 120 patients,” Acta Oncologica, vol. 54, no. 4, pp. 545–551, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Aumock, E. H. Birnbaum, J. W. Fleshman et al., “Treatment of rectal adenocarcinoma with endocavitary and external beam radiotherapy: Results for 199 patients with localized tumors,” International Journal of Radiation Oncology Biology Physics, vol. 51, no. 2, pp. 363–370, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Vuong, P. J. Belliveau, R. P. Michel et al., “Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: Early results of a phase I/II study,” Diseases of the Colon & Rectum, vol. 45, no. 11, pp. 1486–1495, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Vuong, C. Richard, T. Niazi et al., “High dose rate endorectal brachytherapy for patients with curable rectal cancer,” Seminars in Colon and Rectal Surgery, vol. 21, no. 2, pp. 115–119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. P. J. Hoskin, S. M. De Canha, P. Bownes, L. Bryant, and R. G. Jones, “High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma,” Radiotherapy & Oncology, vol. 73, no. 2, pp. 195–198, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Corner, L. Bryant, C. Chapman, R. Glynne-Jones, and P. J. Hoskin, “High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma,” Brachytherapy, vol. 9, no. 1, pp. 66–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Papillon and J. F. Montbarbon, “Epidermoid carcinoma of the anal canal - A series of 276 cases,” Diseases of the Colon & Rectum, vol. 30, no. 5, pp. 324–333, 1987. View at Publisher · View at Google Scholar · View at Scopus
  37. F. M. Smith, A. Al-Amin, A. Wright, J. Berry, J. J. Nicoll, and A. Sun Myint, “Contact radiotherapy boost in association with ‘watch and wait’ for rectal cancer: initial experience and outcomes from a shared programme between a district general hospital network and a regional oncology centre,” Colorectal Disease, vol. 18, no. 9, pp. 861–870, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. A. L. Appelt and D. Sebag-Montefiore, “Technological advances in radiotherapy of rectal cancer: Opportunities and challenges,” Current Opinion in Oncology, vol. 28, no. 4, pp. 353–358, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Engels, K. Tournel, H. Everaert et al., “Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer,” International Journal of Radiation Oncology Biology Physics, vol. 83, no. 1, pp. 142–148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Skowronek and G. Zwierzchowski, “Brachytherapy in the treatment of bile duct cancer - A tough challenge,” Journal of Contemporary Brachytherapy, vol. 9, no. 2, pp. 187–195, 2017. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Karani, M. Fletcher, D. Brinkley, J. L. Dawson, R. Williams, and H. Nunnerley, “Internal biliary drainage and local radiotherapy with iridium-192 wire in treatment of hilar cholangiocarcinoma,” Clinical Radiology, vol. 36, no. 6, pp. 603–606, 1985. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Válek, P. Kysela, Z. Kala, I. Kiss, J. Tomášek, and J. Petera, “Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: A prospective randomised study,” European Journal of Radiology, vol. 62, no. 2, pp. 175–179, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. G. C. Mattiucci, R. Autorino, A. Tringali et al., “A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer,” Brachytherapy, vol. 14, no. 3, pp. 401–404, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Morris, P. J. Eifel, J. Lu et al., “Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer,” The New England Journal of Medicine, vol. 340, no. 15, pp. 1137–1143, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. H. M. Keys, J. A. Roberts, V. L. Brunetto et al., “A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study,” Gynecologic Oncology, vol. 92, no. 3, pp. 744–751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. J. S. Goodwin, J. M. Samet, and W. C. Hunt, “Determinants of Survival in Older Cancer Patients,” JNCI Journal of the National Cancer Institute, vol. 88, no. 15, pp. 1031–1038, 1996. View at Publisher · View at Google Scholar
  47. J. Samet, W. C. Hunt, C. Key, C. G. Humble, and J. S. Goodwin, “Choice of Cancer Therapy Varies With Age of Patient,” Journal of the American Medical Association, vol. 255, no. 24, pp. 3385–3390, 1986. View at Publisher · View at Google Scholar · View at Scopus
  48. M. A. Schonberg, E. R. Marcantonio, D. Li, R. A. Silliman, L. Ngo, and E. P. McCarthy, “Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival,” Journal of Clinical Oncology, vol. 28, no. 12, pp. 2038–2045, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Cykert, P. Dilworth-Anderson, M. H. Monroe et al., “Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer,” Journal of the American Medical Association, vol. 303, no. 23, pp. 2368–2376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Rotman, A. Sedlis, M. R. Piedmonte et al., “A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study,” International Journal of Radiation Oncology Biology Physics, vol. 65, no. 1, pp. 169–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Y. Lin, S. Kondalsamy-Chennakesavan, D. Bernshaw, P. Khaw, and K. Narayan, “Carcinoma of the cervix in elderly patients treated with radiotherapy: Patterns of care and treatment outcomes,” Journal of Gynecologic Oncology, vol. 27, no. 6, article no. e59, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. S.-W. Chen, J.-A. Liang, S.-N. Yang, and F.-J. Lin, “High dose-rate brachytherapy for elderly patients with uterine cervical cancer,” Japanese Journal of Clinical Oncology, vol. 33, no. 5, pp. 221–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Yanazume, S. Yanazume, K. Iio et al., “Major causes of impractical brachytherapy in elderly patients with uterine cervical cancer,” Journal of Obstetrics and Gynaecology Research, vol. 40, no. 6, pp. 1725–1732, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. N. D. Fleming, S. E. Lentz, I. Cass, A. J. Li, B. Y. Karlan, and C. S. Walsh, “Is older age a poor prognostic factor in stage i and II endometrioid endometrial adenocarcinoma?” Gynecologic Oncology, vol. 120, no. 2, pp. 189–192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. J. A. Lachance, E. N. Everett, B. Greer et al., “The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer,” Gynecologic Oncology, vol. 101, no. 3, pp. 470–475, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Siesto, S. Uccella, F. Ghezzi et al., “Surgical and survival outcomes in older women with endometrial cancer treated by laparoscopy,” Menopause, vol. 17, no. 3, pp. 539–544, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Dumas, A. Ring, J. Butler, T. Kalsi, D. Harari, and S. Banerjee, “Improving outcomes for older women with gynaecological malignancies,” Cancer Treatment Reviews, vol. 50, pp. 99–108, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. K. M. Alektiar, E. Venkatraman, N. Abu-Rustum, and R. R. Barakat, “Is Endometrial Carcinoma Intrinsically More Aggressive in Elderly Patients?” Cancer, vol. 98, no. 11, pp. 2368–2377, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. P. De Marzi, J. Ottolina, G. Mangili et al., “Surgical treatment of elderly patients with endometrial cancer (≥65years),” Journal of Geriatric Oncology, vol. 4, no. 4, pp. 368–373, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Jolly, C. E. Vargas, T. Kumar et al., “The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation,” Gynecologic Oncology, vol. 103, no. 1, pp. 87–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Alejandro Rauh-Hain, K. J. Pepin, L. A. Meyer et al., “Management for elderly women with advanced-stage, high-grade endometrial cancer,” Obstetrics & Gynecology, vol. 126, no. 6, pp. 1198–1206, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. J. D. Wright, S. N. Lewin, N. I. Barrena Medel et al., “Endometrial cancer in the oldest old: Tumor characteristics, patterns of care, and outcome,” Gynecologic Oncology, vol. 122, no. 1, pp. 69–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Uccella, M. Bonzini, S. Palomba et al., “Laparoscopic vs. open treatment of endometrial cancer in the elderly and very elderly: An age-stratified multicenter study on 1606 women,” Gynecologic Oncology, vol. 141, no. 2, pp. 211–217, 2016. View at Publisher · View at Google Scholar · View at Scopus
  64. H. Eggemann, T. Ignatov, E. Burger, S. D. Costa, and A. Ignatov, “Management of elderly women with endometrial cancer,” Gynecologic Oncology, vol. 146, no. 3, pp. 519–524, 2017. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Susini, G. Massi, G. Amunni et al., “Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly,” Gynecologic Oncology, vol. 96, no. 2, pp. 362–367, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. Z. Vaknin, I. Ben-Ami, D. Schneider, M. Pansky, and R. Halperin, “A comparison of perioperative morbidity, perioperative mortality, and disease-specific survival in elderly women (≥70 years) versus younger women (<70 years) with endometrioid endometrial cancer,” International Journal of Gynecological Cancer, vol. 19, no. 5, pp. 879–883, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. D. R. Scribner Jr., J. L. Walker, G. A. Johnson, S. D. McMeekin, M. A. Gold, and R. S. Mannel, “Surgical management of early-stage endometrial cancer in the elderly: is laparoscopy feasible?” Gynecologic Oncology, vol. 83, no. 3, pp. 563–568, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. V. Lavoue, X. Zeng, S. Lau et al., “Impact of robotics on the outcome of elderly patients with endometrial cancer,” Gynecologic Oncology, vol. 133, no. 3, pp. 556–562, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. P. T. Truong, H. A. Kader, B. Lacy et al., “The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer,” American Journal of Clinical Oncology, vol. 28, no. 2, pp. 157–164, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. S. W. Dutta, D. M. Trifiletti, S. Grover, P. Boimel, and T. N. Showalter, “Management of elderly patients with early-stage medically inoperable endometrial cancer: Systematic review and National Cancer Database analysis,” Brachytherapy, vol. 16, no. 3, pp. 526–533, 2017. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Kucera, T. H. Knocke, E. Kucera, and R. Potter, “Treatment of endometrial carcinoma with high-dose-rate brachytherapy alone in medically inoperable stage I patients,” Acta Obstetricia et Gynecologica Scandinavica, vol. 77, no. 10, pp. 1008–1012, 1998. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Tarver, “Cancer Facts & Figures 2012. American Cancer Society (ACS),” Journal of Consumer Health On the Internet, vol. 16, no. 3, pp. 366-367, 2012. View at Publisher · View at Google Scholar
  73. F. Fiorica, G. Zini, F. Cartei, M. V. Candela et al., “Radiotherapy and comorbidity assessment in older and oldest elderly endometrial cancer patients: a retrospective analysis,” World Cancer Research Journal, vol. 1, no. 1, p. e55, 2014. View at Google Scholar
  74. S. Kellas-Śleczka, B. Białas, M. Fijałkowski et al., “Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer,” Journal of Contemporary Brachytherapy, vol. 8, no. 1, pp. 32–40, 2016. View at Publisher · View at Google Scholar · View at Scopus
  75. C. Charra, P. Roy, R. Coquard, P. Romestaing, J. M. Ardiet, and J. P. Gérard, “Outcome of treatment of upper third vaginal recurrences of cervical and endometrial carcinomas with interstitial brachytherapy,” International Journal of Radiation Oncology Biology Physics, vol. 40, no. 2, pp. 421–426, 1998. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Makarewicz, “The place of interstitial treatment in the management of vulvar carcinoma,” Reports of Practical Oncology, vol. 1, no. 2, pp. 86–88, 1996. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Hasbini, C. Haie-Meder, P. Morice et al., “Outcome after salvage radiotherapy (brachytherapy +/- external) in patients with a vaginal recurrence from endometrial carcinomas,” Radiotherapy & Oncology, vol. 65, no. 1, pp. 23–28, 2002. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Katz, PJ. Eifel, A. Jhingran, and C. F. Levenback, “The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva,” International Journal of Radiation Oncology Biology Physics, vol. 57, pp. 409–418, 2003. View at Google Scholar
  79. S. Nag, S. Yacoub, L. J. Copeland, and J. M. Fowler, “Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients,” International Journal of Radiation Oncology Biology Physics, vol. 54, no. 4, pp. 1153–1159, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. A. R. Seeger, A. Windschall, M. Lotter et al., “The role of interstitial brachytherapy in the treatment of vaginal and vulvar malignancies,” Strahlentherapie und Onkologie, vol. 182, no. 3, pp. 142–148, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. U. Mahantshetty, P. Naga, R. Engineer et al., “Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: A single institutional experience,” Brachytherapy, vol. 16, no. 1, pp. 153–160, 2017. View at Publisher · View at Google Scholar · View at Scopus
  82. K. S. Tewari, F. Cappuccini, A. A. Puthawala et al., “Primary invasive carcinoma of the vagina: Treatment with interstitial brachytherapy,” Cancer, vol. 91, no. 4, pp. 758–770, 2001. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Pohar, S. Hoffstetter, D. Peiffert, E. Luporsi, and M. Pernot, “Primary invasive carcinoma of the vagina,” Cancer, vol. 91, pp. 758–770, 2001. View at Google Scholar
  84. American cancer Society: Cancer Facts and Figures, American Cancer Society, Atlanta/USA, 2017, https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html.
  85. K. Yoshida, H. Yamazaki, S. Nakamura et al., “Comparisons of late vaginal mucosal reactions between interstitial and conventional intracavitary brachytherapy in patients with gynecological cancer: Speculation on the relation between pallor reaction and stenosis,” Anticancer Reseach, vol. 33, no. 9, pp. 3963–3968, 2013. View at Google Scholar · View at Scopus
  86. G. Kovács, “Modern head and neck brachytherapy: From radium towards intensity modulated interventional brachytherapy,” Journal of Contemporary Brachytherapy, vol. 6, no. 4, pp. 404–416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. C. P. Schofield, A. J. Sykes, N. J. Slevin, and N. Z. Z. Rashid, “Radiotherapy for head and neck cancer in elderly patients,” Radiotherapy & Oncology, vol. 69, no. 1, pp. 37–42, 2003. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Kos, K. Luczak, J. Godzinski, and J. Klempous, “Treatment of monostotic fibrous dysplasia with pamidronate,” Journal of Cranio-Maxillo-Facial Surgery, vol. 32, no. 1, pp. 10–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. G. Kovács, R. Martinez-Monge, A. Budrukkar et al., “GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update – Improvement by cross sectional imaging based treatment planning and stepping source technology,” Radiotherapy & Oncology, vol. 122, no. 2, pp. 248–254, 2017. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Gaztanaga, I. San Miguel, M. E. Rodriquez et al., “289 oral limited-volume perioperative hdr brachytherapy as a substitute for wide-field ebrt in resected head & neck cancer,” Radiotherapy and Oncology, 2011. View at Publisher · View at Google Scholar
  91. K. Yuasa-Nakagawa, R. Yoshimura, H. Watanabe et al., “Brachytherapy for the very elderly with oral and oropharyngeal cancers,” Annals of Oncology, vol. 26, pp. 93–102, 2015. View at Google Scholar
  92. H. Yamazaki, K. Yoshida, T. Kotsuma et al., “Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older,” Journal of Radiation Oncology, vol. 5, no. 1, article no. 116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. R. Khalilur, K. Hayashi, and H. Shibuya, “Brachytherapy for tongue cancer in the very elderly is an alternative to external beam radiation,” British Journal of Radiology, vol. 84, no. 1004, pp. 747–749, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. J.-L. Guinot, L. Arribas, J. B. Vendrell et al., “Prognostic factors in squamous cell lip carcinoma treated with high-dose-rate brachytherapy,” Head & Neck, vol. 36, no. 12, pp. 1737–1742, 2014. View at Publisher · View at Google Scholar · View at Scopus
  95. Y. Zhang, J.-L. Yi, X.-D. Huang et al., “Inherently poor survival of elderly patients with nasopharyngeal carcinoma,” Head & Neck, vol. 37, no. 6, pp. 771–776, 2015. View at Publisher · View at Google Scholar · View at Scopus
  96. H. Zeng, R. Zheng, S. Zhang et al., “Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries,” Thoracic Cancer, vol. 7, no. 2, pp. 232–237, 2016. View at Publisher · View at Google Scholar · View at Scopus
  97. W. Chen, R. Zheng, P. D. Baade et al., “Cancer statistics in China, 2015,” CA: A Cancer Journal for Clinicians, vol. 66, no. 2, pp. 115–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  98. J. S. Cooper, M. D. Guo, A. Herskovic et al., “Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01),” Journal of the American Medical Association, vol. 281, no. 17, pp. 1623–1627, 1999. View at Publisher · View at Google Scholar · View at Scopus
  99. T. Li, W. Zhang, J. Lv et al., “Safety and outcome of external beam radiation and neutron brachytherapy in elderly patients with esophageal squamous cell cancer,” Journal of Contemporary Brachytherapy, vol. 9, no. 1, pp. 36–43, 2017. View at Publisher · View at Google Scholar · View at Scopus
  100. C. D. Amdal, A.-B. Jacobsen, B. Sandstad, T. Warloe, and K. Bjordal, “Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial,” Radiotherapy & Oncology, vol. 107, no. 3, pp. 428–433, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. I. Mallick, S. C. Sharma, and D. Behera, “Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer-Analysis of symptom response, endoscopic improvement and quality of life,” Lung Cancer, vol. 55, no. 3, pp. 313–318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. R. J. McKenna, A. Mahtabifard, J. Yap et al., “Wedge Resection and Brachytherapy for Lung Cancer in Patients With Poor Pulmonary Function,” The Annals of Thoracic Surgery, vol. 85, no. 2, pp. S733–S736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. R. Santos, A. Colonias, D. Parda et al., “Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer,” Surgery, vol. 134, no. 4, pp. 691–697, 2003. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Song, X. Fan, Z. Zhao et al., “125I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy: A comparison with best supportive care,” OncoTargets and Therapy, vol. 10, pp. 1345–1352, 2017. View at Publisher · View at Google Scholar · View at Scopus
  105. A. F. Cardona, L. Reveiz, E. G. Ospina et al., “Medical Policy Endobronchial Brachytherapy,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD004284, 2008. View at Google Scholar
  106. Y. C. Ung, E. Yu, C. Falkson et al., “The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: A systematic review,” Brachytherapy, vol. 5, no. 3, pp. 189–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. V. K. Sangar, N. Ragavan, S. S. Matanhelia, M. W. Watson, and R. A. Blades, “The economic consequences of prostate and bladder cancer in the UK,” BJU International, vol. 95, no. 1, pp. 59–63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. T. A. Stamey, “The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA,” BJU International, vol. 94, no. 7, pp. 963-964, 2004. View at Publisher · View at Google Scholar · View at Scopus
  109. P. J. Hoskin, P. J. Bownes, P. Ostler, K. Walker, and L. Bryant, “High dose rate afterloading brachytherapy for prostate cancer: Catheter and gland movement between fractions,” Radiotherapy & Oncology, vol. 68, no. 3, pp. 285–288, 2003. View at Publisher · View at Google Scholar · View at Scopus
  110. F. A. Vicini, A. Martinez, G. Hanks et al., “An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up,” Cancer, vol. 95, no. 10, pp. 2126–2135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. M. R. Cooperberg, D. P. Lubeck, M. V. Meng, S. S. Mehta, and P. R. Carroll, “The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management,” Journal of Clinical Oncology, vol. 22, no. 11, pp. 2141–2149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  112. Y.-N. Wong, N. Mitra, G. Hudes et al., “Survival associated with treatment vs observation of localized prostate cancer in elderly men,” The Journal of the American Medical Association, vol. 296, no. 22, pp. 2683–2693, 2006. View at Publisher · View at Google Scholar · View at Scopus
  113. Y. Yamada, S. Bhatia, M. Zaider et al., “Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer,” Brachytherapy, vol. 5, no. 3, pp. 157–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. N. Zamboglou, N. Tselis, D. Baltas et al., “High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: Treatment evolution and mature results,” International Journal of Radiation Oncology • Biology • Physics, vol. 85, no. 3, pp. 672–678, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. A. L. Liss, E. I. Abu-Isa, M. S. Jawad et al., “Combination therapy improves prostate cancer survival for patients with potentially lethal prostate cancer: The impact of Gleason pattern 5,” Brachytherapy, vol. 14, no. 4, pp. 502–510, 2015. View at Publisher · View at Google Scholar · View at Scopus
  116. K. E. Hoffman, M.-H. Chen, B. J. Moran et al., “Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer,” Cancer, vol. 116, no. 11, pp. 2590–2595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. J. Skowronek, “Brachytherapy in the therapy of prostate cancer - An interesting choice,” Wspolczesna Onkologia, vol. 17, no. 5, pp. 407–412, 2013. View at Publisher · View at Google Scholar · View at Scopus
  118. I. Henríquez, G. Sancho, A. Hervás et al., “Salvage brachytherapy in prostate local recurrence after radiation therapy: Predicting factors for control and toxicity,” Journal of Radiation Oncology, vol. 9, no. 1, article no. 102, 2014. View at Publisher · View at Google Scholar · View at Scopus
  119. P. Niehoff, T. Loch, N. Nürnberg et al., “Feasibility and preliminary outcome of salvage combined HDR brachytherapy and external beam radiotherapy (EBRT) for local recurrences after radical prostatectomy,” Brachytherapy, vol. 4, no. 2, pp. 141–145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  120. M. A. Bernier, F. R. Ruiz, M. De Troya Martín, and N. B. Sánchez, “Comparative epidemiological study of non-melanoma skin cancer between Spanish and north and central European residents on the Costa del Sol,” Journal of the European Academy of Dermatology and Venereology, vol. 26, no. 1, pp. 41–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  121. Wu. TP and JA. Stein, “Non-melanoma skin cancer in young women,” Journal of Drugs in Dermatology, vol. 12, pp. 568–572, 2013. View at Google Scholar
  122. C. M. Clark, M. Furniss, and J. M. Mackay-Wiggan, “Basal cell carcinoma: An evidence-based treatment update,” American Journal of Clinical Dermatology, vol. 15, no. 3, pp. 197–216, 2014. View at Publisher · View at Google Scholar · View at Scopus
  123. F. J. Bath-Hextall, W. Perkins, J. Bong, and H. C. Williams, “Interventions for basal cell carcinoma of the skin,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD003412, 2007. View at Google Scholar · View at Scopus
  124. R. Ballester-Sánchez, O. Pons-Llanas, C. Candela-Juan et al., “Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma,” Journal of Contemporary Brachytherapy, vol. 7, no. 3, pp. 231–238, 2015. View at Publisher · View at Google Scholar · View at Scopus
  125. R. Jumeau, S. Renard-Oldrini, F. Courrech et al., “High dose rate brachytherapy with customized applicators for malignant facial skin lesions,” Cancer Radiothérapie, vol. 20, no. 5, pp. 341–346, 2016. View at Publisher · View at Google Scholar · View at Scopus
  126. G. G. Kimmick and L. Balducci, “Breast cancer and aging: Clinical interactions,” Hematology/Oncology Clinics of North America, vol. 14, no. 1, pp. 213–234, 2000. View at Publisher · View at Google Scholar · View at Scopus
  127. R. Yancik, “Cancer burden in the aged: An epidemiologic and demographic overview,” Cancer, vol. 80, no. 7, pp. 1273–1283, 1997. View at Publisher · View at Google Scholar · View at Scopus
  128. L. Talarico, G. Chen, and R. Pazdur, “Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration,” Journal of Clinical Oncology, vol. 22, no. 22, pp. 4626–4631, 2004. View at Publisher · View at Google Scholar · View at Scopus
  129. N. Hébert-Croteau, J. Brisson, J. Latreille, C. Blanchette, and L. Deschênes, “Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women,” Cancer, vol. 85, no. 5, pp. 1104–1113, 1999. View at Publisher · View at Google Scholar · View at Scopus
  130. C. Bouchardy, E. Rapiti, G. Fioretta et al., “Undertreatment strongly decreases prognosis of breast cancer in elderly women,” Journal of Clinical Oncology, vol. 21, no. 19, pp. 3580–3587, 2003. View at Publisher · View at Google Scholar · View at Scopus
  131. R. A. Silliman, S. L. Troyan, E. Guadagnoli, S. H. Kaplan, and S. Greenfield, “The impact of age, marital status, and physician-patient interactions on the care of older women with breast carcinoma,” Cancer, vol. 80, no. 7, pp. 1326–1334, 1997. View at Publisher · View at Google Scholar · View at Scopus
  132. K. S. Hughes, L. A. Schnaper, J. R. Bellon et al., “Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343,” Journal of Clinical Oncology, vol. 31, no. 19, pp. 2382–2387, 2013. View at Publisher · View at Google Scholar · View at Scopus
  133. I. H. Kunkler, L. J. Williams, W. J. L. Jack, D. A. Cameron, and J. M. Dixon, “Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): A randomised controlled trial,” The Lancet Oncology, vol. 16, no. 3, pp. 266–273, 2015. View at Publisher · View at Google Scholar · View at Scopus
  134. S. Sumodhee, J. Levy, E. Chamorey et al., “Accelerated partial breast irradiation for elderly women with early breast cancer: A compromise between whole breast irradiation and omission of radiotherapy,” Brachytherapy, vol. 16, no. 5, pp. 929–934, 2017. View at Publisher · View at Google Scholar · View at Scopus
  135. C. Genebes, M.-E. Chand, J. Gal et al., “Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy,” Journal of Radiation Oncology, vol. 9, no. 1, article no. 115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  136. V. Valentini, F. Miccichè, L. Tagliaferri et al., “Spider-H&N: Managing clinical data of head&neck cancer patients treated through a multidisciplinary approach,” Radiotherapy & Oncology, vol. 82, pp. S76–S77, 2007. View at Publisher · View at Google Scholar
  137. L. Tagliaferri, G. Kovács, R. Autorino et al., “ENT COBRA (Consortium for Brachytherapy Data Analysis): Interdisciplinary standardized data collection system for head and neck patients treated with interventional radiotherapy (brachytherapy),” Journal of Contemporary Brachytherapy, vol. 8, no. 4, pp. 336–343, 2016. View at Publisher · View at Google Scholar · View at Scopus